-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Mirum Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2019 to Q3 2024.
- Mirum Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $11.9M, a 42% increase year-over-year.
- Mirum Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $44.9M, a 39.5% increase year-over-year.
- Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35M, a 29.7% increase from 2022.
- Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $27M, a 17.3% increase from 2021.
- Mirum Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $23M, a 83.3% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)